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The Rho3 and Cdc42 members of the Rho GTPase family are important regulators of exocytosis in yeast. However, the
precise mechanism by which they regulate this process is controversial. Here, we present evidence that the Exo70
component of the exocyst complex is a direct effector of both Rho3 and Cdc42. We identify gain-of-function mutants in
EXO70 that potently suppress mutants in RHO3 and CDC42 defective for exocytic function. We show that Exo70 has the
biochemical properties expected of a direct effector for both Rho3 and Cdc42. Surprisingly, we find that C-terminal
prenylation of these GTPases both promotes the interaction and influences the sites of binding within Exo70. Finally, we
demonstrate that the phenotypes associated with novel loss-of-function mutants in EXO70, are entirely consistent with
Exo70 as an effector for both Rho3 and Cdc42 function in secretion. These data suggest that interaction with the Exo70
component of the exocyst is a key event in spatial regulation of exocytosis by Rho GTPases.
INTRODUCTION
The ability of eukaryotic cells to grow asymmetrically relies
on the delivery of lipids and proteins to specific sites on the
cell surface. This delivery is largely mediated by the docking
and fusion of secretory vesicles with a precisely demarcated
region of the plasma membrane. The budding yeast Saccha-
romyces cerevisiae undergoes polarized growth throughout
its cell cycle, which makes it an attractive model for studying
the regulation of polarized exocytosis and its role in overall cell
polarity. An important factor in targeting of secretory vesicles
to the plasma membrane is an evolutionary conserved eight-
subunit protein complex, known as the exocyst complex,
which is composed of Sec3, Sec5, Sec6, Sec8, Sec10, Sec15,
Exo70, and Exo84 (for review, see Nelson and Yeaman, 2001;
Hsu et al., 2004; Munson and Novick, 2006; Wu et al., 2008).
Both Rab and Rho family small GTPases have been shown
to be the upstream regulators of exocyst function in vesicle
docking and fusion. The Rab family small GTPase, Sec4,
directly interacts with the Sec15 subunit of the exocyst, and
it is this interaction that is thought to help link the exocyst
complex to the vesicle during docking (Guo et al., 1999). The
Rho family small GTPases are also important regulators of
polarized exocytosis in yeast. Previous studies have shown
that specific conditional mutations in Rho3 or Cdc42 results
in actin-independent defects in exocytosis (Adamo et al.,
1999, 2001). Although Rho3 and Cdc42 seem to have par-
tially overlapping functions, they are also individually re-
quired for polarized exocytosis; loss of function in each
GTPase shows a specific set of phenotypes when their se-
cretory function is impaired. The secretory-defective mutant
form of Cdc42, cdc42-6, accumulates post-Golgi vesicles only
during bud emergence (i.e., small-budded cells) and dis-
plays a pronounced defect in secretion of Bgl2 but not in
secretion of invertase. In contrast, the secretory defective
form of Rho3, rho3-V51, accumulates post-Golgi vesicles
throughout the cell cycle and has pronounced defects in
secretion of both Bgl2 and invertase pathways.
Exo70 has been implicated as a possible effector for Rho3
based on its ability to interact with Rho3 in a GTP-depen-
dent manner (Robinson et al., 1999), and the fact that the
interaction of Rho3 with Exo70 is blocked by the presence of
the rho3-V51 effector domain mutation (Adamo et al., 1999).
Interestingly, recent studies have identified exo70 mutant
alleles, exo70-35 and exo70-38, that demonstrate a small-bud–
specific and Bgl2-specific secretion defect, phenotypes that are
remarkably similar to that of cdc42-6. These results could sug-
gest a role for Exo70 as a target for Cdc42 during exocytosis,
however, a physical interaction between activated recombinant
Cdc42 and Exo70 was not detected (He et al., 2007a).
The recent determination of the crystal structure of Exo70
proteins from yeast and mice revealed a conserved rod
structure with four domains arranged sequentially from the
N to the C terminus (Dong et al., 2005; Hamburger et al.,
2006; Moore et al., 2007). Structural similarity also seems to
exist between the C-terminal domain of Exo70 and other
members of the exocyst complex (Dong et al., 2005; Munson
and Novick, 2006; Sivaram et al., 2006). However, despite the
conservation in overall structure of yeast and mammalian
Exo70, the site of interaction with Rho family GTPases
seemed to be quite distinct. Although recombinant Rho3
was found to bind primarily through interactions within the
C domain of yeast Exo70, the site of interaction between the
mouse Cdc42 homologue TC10 and mouse Exo70 was
mapped to the N-terminal AB domains (Chiang et al., 2001).
Recent work has called into question the role of Exo70 as
an effector of Rho3 function in exocytosis. Examination of
two alleles in EXO70 suggested that Exo70 function was
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required only in small-budded cells (He et al., 2007a), in
contrast to studies on Rho3 demonstrating exocytic defects
in both small and large budded yeast (Adamo et al., 1999,
2001). More importantly, mutants or deletions in Exo70 pre-
dicted to block the interaction with Rho3 in vitro, showed
little to no effect on growth or secretory function of EXO70
(He et al., 2007b; Hutagalung et al., 2009). Together, these
results suggested that Exo70 was unlikely to be the effector
for Rho3 function in exocytosis.
In the current study, we report a combination of genetic and
biochemical examinations to determine the possible role of
Exo70 as a target of Rho3 and Cdc42 function in exocytosis.
First, we describe the isolation of dominant gain-of-function
alleles of EXO70 that strongly suppress the loss of either Rho3
or Cdc42 function in the exocytic pathway. Second, we de-
scribe a biochemical assay using posttranslationally modified
forms of Rho3 and Cdc42 to demonstrate that Exo70 has the
biochemical properties of a direct effector for both of these
GTPases. Interestingly, we found that C-terminally prenylated
forms of Rho3 and Cdc42 are able to interact with Exo70 in a
manner that is structurally distinct from that of unmodified
recombinant Rho3. Finally, we describe the isolation of novel
recessive alleles of EXO70 that demonstrates that the spectrum
of phenotypes associated with Exo70 loss of function is in
strong agreement with its role as an effector for both Cdc42 and
Rho3 function in polarized exocytosis.
MATERIALS AND METHODS
Yeast Strains, Reagents, and Genetic Techniques
Cells were grown in YPD media containing 1% bacto-yeast extract, 2% bacto-
peptone, and 2% glucose. The components of the media were from Thermo
Fisher Scientific (Waltham, MA). For all assays performed, 25°C was the
permissive temperature, whereas 14 and 37°C were used as the restrictive
temperatures. Sorbital, sodium azide (NaN3), N-ethylmaleimide (NEM),
-mercaptoethanol, o-dianasidine, glucose oxidase, peroxidase, Triton X-100,
NP-40, and HIS-Select Nickel Affinity Gel were obtained from Sigma-Aldrich
(St. Louis, MO). Zymolyase (100T) was from Seikagaku (Tokyo, Japan). Bo-
vine serum albumin, yeast nitrogen base, raffinose galactose, and 5-fluoro-
orotic acid (5-FOA) were from United States Biologicals (Swampscott, MA).
Glutathione-Sepharose beads and protein A beads were from GE Healthcare
(Little Chalfont, Buckinghamshire, United Kingdom). Guanosine 5-O-(3-thio)t-
riphosphate (GTPS) and guanosine diphosphate (GDP) were from Roche Ap-
plied Science (Indianapolis, IN). Secondary antibodies for Odyssey imaging
system were from LI-COR Biosciences (Lincoln, NE) and Invitrogen (Carlsbad,
CA). Rabbit anti-mouse antibody was from Jackson ImmunoResearch Labora-
tories (West Grove, PA). Formaldehyde (37%), glutaraldehyde, and Spurr’s
resin were from Electron Microscopy Sciences (Ft. Washington, PA). The TNT
in vitro translation system for polymerase chain reaction (PCR) products was
from Promega (Madison, WI). l-[35S]Methionine was from PerkinElmer Life
and Analytical Sciences (Boston, MA). Mevalonic acid was from Sigma-
Aldrich. The bead beater for making yeast lysate is from BioSpec Products
(Bartlesville, OK). Transformations for suppression analysis were performed
using the lithium acetate method described in Guthrie and Fink (1991). Strain
crossing, tetrad dissection, diploid sporulation, and mating-type determina-
tion were performed as described by Guthrie and Fink (1991).
Dominant Suppressor Screen for Exo70 Dominant Mutants
The EXO70 dominant mutants in this study were generated by Error-prone
PCR as described below. Fifty nanograms of digested vector and 3 l of
PCR reaction were transformed into the RHO3 plasmid shuffle strain
(rho3::LEU2;his3-200, ura3-52;leu2-3112; pRS316-RHO3,URA3,CEN,) and the
cdc42-6 strain (BY648 , cdc42-6, leu2,3-112; ura3-52). CEN HIS3 vector was
used for RHO3 plasmid shuffle strain, and CEN URA3 vector was used for
cdc42-6 strain. Transformants were first grown on selective media for 2 d and
then replica plated onto 5-FOA plates at 30°C for the RHO3 plasmid shuffle
strain and YPD plates at 32°C for cdc42-6 mutant strain. Colonies from the
restrictive conditions were grown in liquid media for plasmid recovery. The
plasmids were retransformed into RHO3 plasmid shuffle strain and cdc42-6
mutant strain to confirm that the plasmids were responsible for the gain of
function phenotype. From 6030 transformants from the RHO3 plasmid shuffle
strain, we isolated three plasmids that suppressed the rho3 at 30°C. From
5660 transformants in the cdc42-6 strain, we isolated 38 plasmids that had the
ability to suppress the temperature sensitivity of the cdc42-6 mutant at 32°C.
Isolation of Novel Exo70 Mutants by Random
Mutagenesis
The EXO70 mutants isolated in this study were generated by GeneMorph II
random mutagenesis kit (Stratagene, La Jolla, CA). Then, 50 ng of plasmid
pRS315 Exo70 was used as a template for PCR reaction performed under
conditions that produce 0–4.5 mutations/kb (low frequency of mutagenesis)
according to the manufacturer’s protocol. Oligonucleotide primers were de-
signed to generate mutagenized PCR products containing the EXO70 open
reading frame flanked by 629 base pairs of 5 and 295 bp of 3 sequence. The
EXO70 gap repair vector (BB1673) was digested with BamHI and XbaI. Then,
50 ng of digested vector were cotransformed with 3 l of PCR product into
EXO70 plasmid shuffle strain (BY861: exo70::HIS3;his3-200, ura3-52;leu2-
3112; pRS316-EXO70,URA3,CEN). Transformants that repaired the gapped
plasmid by homologous recombination were selected at 30°C on SD plates for
2 d. Transformants that could lose the wild-type plasmid pRS316 Exo70 were
selected by replica plating onto synthetic minimal media containing 5-FOA
while simultaneously selecting for the temperature sensitivity by incubation
of replica plates at 37, 25, 17, and 14°C.
From 10,396 colonies, 40 colonies exhibited temperature sensitivity and 57
colonies exhibited cold sensitivity. Plasmids from these colonies were isolated
and transformed back into the original EXO70 plasmid shuffle strain (BY861)
to confirm that the plasmids were responsible for the temperature sensitivity
and cold sensitivity. One plasmid was found to give rise to a cold-sensitive
phenotype (exo70-188) and one plasmid was found to have a temperature
sensitive phenotype (exo70-113). Sequence analysis demonstrated that the
cold-sensitive mutant, exo70-188, contained the three mutations S305G, T523P,
and L621I. Analysis of the temperature-sensitive allele exo70-113 contained
two mutations: N79K and incorporation of a stop codon at Y327 leading to
truncation of the C-terminal half of the predicted protein.
Genetic Analysis of Mutants
To study the phenotypes of exo70-188 and exo70-113 alleles as the only copy of
Exo70, the constructs were integrated into the chromosome of the diploid
strain BY841 (a/; exo70::HIS3/EXO70; his3200/his3200; ura3-52/ura3-52;
leu2-3112/leu2-3112) at the EXO70 locus. Transformants were sporulated and
tetrads were dissected with the use of a micromanipulator on YPD plates. The
plates were grown at 25°C and the haploid progeny were analyzed for the
presence of the mutants (scored as KanR), the absence of the wild-type EXO70
(scored as his3200), viability, and conditional growth defects.
Electronic Microscopy
The exo70-188 and exo70-113 mutants were grown overnight to mid-log phase
in YPD media. Half of the cultures were shifted to restrictive temperature for
various time periods. The exo70-188 mutant was shifted to a 14°C water bath
shaker for 9 h, where the exo70-113 mutant was shift to 37°C water bath shaker
for 1.5 h. Shifted and unshifted cells were processed as described previously
(Adamo et al., 1999).
Invertase Assay and Bgl2 Assay
The EXO70, exo70-188, exo70-113, rho3-V51, and sec6-4 cells were grown overnight
to mid-log phase at 25°C in YPD liquid media. For the cold-sensitive strains
exo70-188 and rho3-v51, the cells were preshifted to the restrictive temperature of
14°C for 1 h. After the preshift, one sample was taken as T0 and the rest of the
cells were shifted to prechilled YP media containing 0.1% glucose for 9 h.
Samples after the temperature shift were collected as Tfinal. For temperature-
sensitive alleles exo70-113 and sec6-4, the cells were directly shifted to warm YP
media containing 0.1% glucose for 1.5 h at 37°C. Samples collected before and
after the temperature shift were collected as T0 and Tfinal, respectively.
After the temperature shift, the cells were spheroplasted and the internal
and external fractions were separated. Samples were processed as described
previously (Adamo et al., 1999; Lehman et al., 1999). The percentage of internal
invertase accumulation is calculated by: internal/( internal   external).
To analyze the accumulation of Bgl2 enzyme, cells were grown in YPD
media overnight to mid-log phase. The exo70-188 mutant cells were then
shifted to a 14°C water bath shaker for 10 h. The exo70-113 mutant cells were
shifted to 37°C water bath shaker for 2 h. The cells were spheroplasted, and
the internal and external fractions were separated. Samples were boiled with
6x sample buffer for 5 min at 95°C. Internal and external samples were then
subjected to SDS-polyacrylamide gel electrophoresis (PAGE) gel, transferred
to nitrocellulose, and blotted with affinity purified anti-Bgl2 antibody at a
dilution of 1:100. Quantification of the western blots was analyzed by Odys-
sey infrared imaging system (LI-COR Biosciences).
Construction of pGEX-6His Vector and Protein
Expression, Purification, and Quantification
The pGEX6p1 vector was digested with NotI and SalI. An additional PreScission
enzyme site and a 6-histidine tag were generated by fusion PCR reaction and
introduced into the Not1 and Sal1 sites of pGEX6p1 to create pGEX-6P6H
(pB1579). The resulting plasmid contained an N-terminal glutathione transferase
(GST) tag and a C-terminal 6xHis tag flanking the polylinker and was used to
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create the following GST-fusion constructs: GST-Sec9 (aa 402-651), GST-Ste20 (aa
314-432), GST-Exo70 (aa 1-623), GST-Exo70-1521, GST-Exo70-DC. GST-Sec4 (1-
211), GST-Rho1 (aa 1-205), GST-Rho2 (aa1-188), GST-Rho3 (aa 1-227), GST-Rho4
(aa 1-287), and GST-Cdc42 (aa 1-187) were subcloned into pGEX-6p-1 vector. All
constructs were confirmed by sequencing and protein expression was performed
in Escherichia coli BL21 cells. Cells were grown at 37°C in Terrific broth medium
to an OD599 2.0–2.5. Cells were shifted to 25°C, and protein expression was
induced with 0.1 mM isopropyl -d-thiogalactoside for 3 h at 25°C. To maximize
protein solubility, GST-Exo70-ABD was induced at 22°C for 4 h. Cells were
pelleted and frozen at 80°C until lysis.
6xHis-tag purification was performed by binding the bacteria lysate to
HIS-Select Nickel Affinity Gel (Sigma-Aldrich) and then eluting with 500 mM
imidazole. The 6xHistidine eluates were then incubated with glutathione-
Sepharose beads at 4°C for 1 h, and the beads were washed with wash buffer
(20 mM Tris, pH 7.5, 120 mM NaCl, and 1% Tween 20) to remove unbound
proteins. Protein concentration was determined by comparison to purified
protein standards after SDS-PAGE and Coomassie Blue staining. Quantifica-
tion of Coomassie Blue-stained gels was performed by Odyssey infrared
imaging system (LI-COR Biosciences).
In Vitro Binding Assays
Glutathione beads carrying GST,GST-Rho1-4, GST-Cdc42 were washed with
20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1 mM dithiothreitol (DTT) and
were incubated in 20 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, and 1 mM
DTT in the presence of 100 M GTPS for 30 min at 25°C. MgCl2 was added
to a final concentration of 25 mM and incubated 30 min at 25°C. Binding
assays were performed in binding buffer (20 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 5 mM MgCl2, 1 mM DTT, and 0.5% Triton X-100). The final concentra-
tions of GST, GST-Rho1-4, and GST-Cdc42 in the binding reactions were 2
M. Samples were incubated at 4°C for 2 h. The beads were washed five times
with binding buffer and boiled with 85 l of sample buffer at 95°C for 5 min.
Samples were subjected to SDS-PAGE and autoradiography.
Generation of Yeast Cell Lysate
RHO3L74, RHO3N30, CDC42L61, CDC42N17, and RHO1L68 were amplified
by PCR reaction and subcloned behind the GAL1 promoter in a LEU2 inte-
grating vector (BB24, pRS305 with GAL1 promoter). The vector was linear-
ized by digesting with BstXI restriction enzyme and transformed into a Gal
strain BY17 (a; GAL1; leu2-3112; ura3-52). Yeast strains were first grown in YP
3% raffinose overnight at 30°C to mid-log phase of OD 1–1.5. The small
GTPases were induced by adding final concentration of 1% galactose for two
more doublings (4 h) at 30°C. Cells were pelleted by centrifugation at 5000
rpm for 5 min and washed with double-distilled H2O. Pellets were immedi-
ately frozen on dry ice. Frozen pellets were lysed with a bead beater from
BioSpec Products. The optimal wet weight for the small chamber was 5–6 g.
The pellet was beaten for 1 min followed by a 3-min pause for five cycles.
Lysate was then subjected to centrifugation for 10 min at 17,000  g, followed
by ultracentrifugation at 100,000  g for 30 min. The protein concentration of
the lysate was measured by a Bradford assay (Bradford, 1976). Each lysate was
normalized to 25 mg/ml total protein concentration and frozen on dry ice.
GST Pull-Down from Yeast Cell Lysate
All recombinant proteins were present at a final concentration of 3 M. Cell
lysates were prepared for GST pull-down experiments as described above
and incubated with each fusion protein bound to glutathione-Sepharose
beads for 1.5 h at 4°C. The beads were washed five times with lysis buffer (20
mM Tris-HCl, pH 7.5, 120 mM NaCl, 10 mM MgCl2, 1% Tween 20, and 1 mM
DTT), and boiled at 95°C for 5 min. Samples were subjected to SDS-PAGE gel,
and analyzed by immunoblotting with Rho1, Rho3, and Cdc42 monoclonal
antibody. Quantification of Western blots was performed with Odyssey in-
frared imaging system (LI-COR Biosciences).
In Vitro Prenylation Assay
The coding sequence of Rho3 was amplified by PCR reaction using standard PCR
conditions. A common TNT-T7 primer was designed especially for in vitro
transcription/translation, which contains a promoter and a Kozak consensus
sequence (GCATGGATCCTAATACGACTC ACTATA GGA CAA CAG CCA
CCA TGG GA). Then, 10 l of rabbit reticulocyte lysate, 0.5 l of [35S]methionine,
and 200 ng of amplified DNA (7 l PCR reaction) were first incubated at 30°C
for 1.5 h, and 5 mM mevalonic acid was added to the reaction for 6 h. The
mevalonic acid was prepared as described previously (Hancock, 1995). At the
end of the in vitro translation and prenylation reaction, 75 l of binding buffer (20
mM Tris-HCl, pH 7.5, 120 mM NaCl, 10 mM MgCl2, 1% Tween 20, and 1 mM
DTT) was added to each translation mix and incubated with 15 l of GST-Sec9,
GST-Exo70, or GST-Ste20 for 2 h at 4°C. The beads were washed five times with
binding buffer and boiled with 85 l of sample buffer at 95°C for 5 min. Samples
were subjected to SDS-PAGE, and the gels were quantitated with Storm Phos-
phorImager with ImageQuant software (GE Healthcare).
Immunoprecipitation of the Exocyst Complex
Strains containing dominant mutants of Exo70 as the only source of Exo70
were grown to mid-log phase in SC media at 30°C and shift to YPD rich media
for 1.5 h. The 300 OD units of cells were pelleted and washed with cold
10:20:20 buffer (10 mM Tris, pH 7.5, 20 mM NaN3, and 20 mM NaF). Pellets
were resuspended in lysis buffer [20 mM piperazine-N,N-bis(2-ethanesul-
fonic acid) (Pipes) pH 6.8, 120 mM NaCl, 1 mM EDTA, and 1 mM DTT]. Cells
were lysed by bead beating in lysis buffer and extracted by adding 5
extraction buffer (20 mM Pipes, pH 6.8, 120 mM NaCl, 1 mM EDTA, 1%
NP-40, and 1 mM DTT). Lysates were cleared by centrifugation at 14,000 rpm
for 9 min and normalized for total protein concentration by Bradford assay
(Bradford, 1976). The supernatants were added to prewashed protein beads
for 30 min on ice to reduce nonspecific binding and then spun for 5 min at
14,000 rpm. Input samples were collected, and the remaining lysate was
placed in fresh Eppendorf tubes in the presence of 9E10 monoclonal anti-myc
antibody. Samples were incubated on ice for 45 min, and then we added 2 l
of rabbit anti-mouse antibody followed by incubation on ice for another 30 min.
Lysate-antibody mix was then added to fresh, prewashed protein A beads for 60
min on ice. Samples were washed five times with wash buffer (20 mM Pipes, pH
6.8, 120 mM NaCl, 1 mM EDTA, and 1% NP-40) and boiled at 95°C for 5 min with
2 sample buffer. Input and bound fractions were analyzed by SDS-PAGE gels
and Western blotting. Quantitation of Western blots was performed by Odyssey
infrared imaging system (LI-COR Biosciences).
RESULTS
Isolation of Dominant Gain-of-Function Alleles of EXO70
We have suggested previously a model for localized stimu-
lation of exocytosis by the guanosine triphosphate (GTP)-
bound forms of Rho3 and Cdc42. For Rho3, we proposed
this activation would involve interaction with the Exo70
subunit of the exocyst complex, whereas the effector for
Cdc42 was unknown (Roumanie et al., 2005; Wu et al., 2008).
Using other Rho-effectors such as formins, Wiskott–Aldrich
Syndrome protein, or p21-activated kinase kinases, as a
model, one might expect that downstream activation would
involve “relief of autoinhibition,” i.e., that binding of Rho3-
GTP to the Exo70 subunit of the exocyst would activate this
complex by blocking inhibitory interactions between Exo70
and other components of the complex, thus reorganizing the
complex into a more active form (Wu et al., 2008). A predic-
tion of this model is that mutations in Exo70 that block or
perturb inhibitory interactions of Exo70 within the exocyst
should act as “activated” or gain-of-function alleles and
would behave genetically as dominant-suppressors of loss
of Rho3 function. Furthermore, if Rho3 and Cdc42 share a
common pathway in regulating exocyst function then mu-
tants that suppress loss of Rho3 function in exocytosis
should also suppress loss of Cdc42 function in exocytosis.
To test these predictions, we performed two independent
screens to look for dominant suppressing forms of EXO70.
One screen made use of the rho3 mutant, which is sensitive
to increased gene dosage of several components of the exo-
cytic apparatus (Matsui and Toh, 1992; Imai et al., 1996;
Lehman et al., 1999). The other screen made use of the
cdc42-6 mutant that has a highly allele-specific defect in
exocytosis that genetically overlaps with that of Rho3 (Ad-
amo et al., 2001). EXO70 was randomly mutagenized by PCR
amplification and introduced into the mutant yeast strains
by cotransformation with a gap-repair plasmid containing
the flanking sequences of the EXO70 gene (see Materials and
Methods). Approximately 6000 transformants were assayed
from each strain and 45 plasmids containing dominant
suppressing forms of EXO70 were isolated from both
screens. Our initial work focused on the 41 strongest sup-
pressors. When we examined the strongest 16 EXO70 dom-
inant suppressors isolated from the cdc42-6 screen in the
rho3 strain, we found that they also strongly suppressed
(Supplemental Figure S1). When we examined the ability of
the 3 strongest EXO70 dominant suppressors isolated from
the rho3 screen to suppress cdc42-6 we found that all but
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one of these also strongly suppressed cdc42-6 (Supplemental
Figure S1A). We also examined all 16 mutants in rho3,
rho4 and found they all strongly suppressed (Supplemental
Figure S1B). Therefore, each of these two genetic screens
appeared to be selecting for mutants in EXO70 with similar
properties. The ability of these suppressors to potently sup-
press growth defects associated with both rho3 and cdc42
loss-of-function strongly supports the idea that Exo70 is a
functionally important downstream target of regulation by
both of these Rho GTPases.
Sequence analysis of 41 of the strongest suppressors identi-
fied an average of five to eight coding sequence changes per
dominant suppressing allele. This was not unexpected, as the
predicted frequency of mutations for the amplifying conditions
used was 1- to 2-base pair changes/kb. To identify specific
amino acid substitutions linked to the suppression activity, we
scanned the mutant sequences for missense mutations that
appeared in two or more of the suppressing plasmids. This
identified 10 single residue mutations as candidate residues to
confer dominant suppression on Exo70. These mutations were
then prepared as single residue changes and tested for domi-
nant suppression in rho3 or cdc42-6 (Figure 1).
The placement of the dominant gain-of-function muta-
tions in the crystal structure of yeast Exo70 revealed a num-
ber of possible sites of regulation. Three residues, I114, G388,
and N479, are buried within the structure. The other seven
mutations are all surface exposed residues. Charged resi-
dues at the D domain form two patches—D541 and E547
form one patch and E557, K564, and R623 form another
patch. N479 and G388 are located at the interface of the B
and C domains, which potentially cause rearrangements of
the two domains relative to each other within the structure
of Exo70. An alignment of Exo70 protein sequences from
yeast, mouse, worm, and fly is shown in Supplemental
Figure S2. The site of each dominant suppressing mutation
is indicated on the alignment along with the overall conser-
vation of each residue. As can be seen in Supplemental
Figure S2, six of the dominant suppressing mutations occur
in highly conserved residues (I114, N479, D541, E547, E557,
K564)—four of which reside in a single helix (H17) within
the Exo70 crystal structure—suggesting this may be a “hot
spot” for activation of the exocyst by Exo70. Together, how-
ever, the results of this screen overall suggest that there are
likely to be multiple, structurally distinct mechanisms by
which EXO70 gain of function can be achieved.
One possible mechanism for activation of the exocyst com-
plex by the gain-of-function mutants is by effecting the assem-
bly or disassembly of individual subunits of the complex. To
determine whether this was the case, we examined the assem-
bly state of the exocyst complex in the presence of the EXO70
gain-of-function alleles as the sole source of Exo70 in the cell.
We immunoprecipated wild-type and mutant exocyst com-
plexes using strains containing a C-terminally myc-tagged
form of SEC8 (Sec8-myc) and anti-myc antibody-coated beads
Figure 1. Dominant mutations of EXO70 are
able to suppress rho3 and cdc42-6 mutants. (A)
The structure of S. cerevisiae Exo70 (residues
62-623) is in a transparent surface representa-
tion with mutant residues in a space-filing
model. The domains are labeled A–D from the
N terminus to the C terminus. The arrows point
to the residues involved in Exo70 gain of func-
tion mutations. Residues colored in blue repre-
sent highly conserved residues, residues col-
ored in yellow represent residues conserved
only within fungi, and residues colored in pink
represent variable residues. Three residues,
I114, G388, and N479, are buried within the
structure, whereas the remaining seven muta-
tions are surface-exposed residues. The image
was generated using the PDB file 2B1E. (B) The
gain-of-function mutations of EXO70 are capa-
ble of suppressing a rho3 and the cdc42-6 mu-
tant at the restrictive temperature. Dominant
mutants of EXO70 were transformed into a
RHO3 plasmid shuffle strain and a cdc42-6
strain on CEN plasmids. The growth of three
independent transformants is shown for each
EXO70 mutant in both mutant strains under
restrictive conditions. (C) The EXO70 dominant
mutations can function as the sole copy of
Exo70 in the cell. The dominant mutations were
introduced into the EXO70 plasmid shuffle
strain on a CEN-LEU2 plasmid. Three individ-
ual colonies were picked to show the growth of
each EXO70 mutant under restrictive condi-
tions when the plasmid containing wild-type
EXO70-URA3 was lost by counterselection on
5-FOA plates. (D) EXO70 dominant mutants
express similar amounts of Exo70 compared
with wild-type cells. Whole cell lysate were
made from the strains containing Exo70 gain of
function mutants as the only source of EXO70
in the cell. The lysates were subjected to SDS-
PAGE analysis and blotted with anti-Myo2 and
anti-Exo70 antibodies.
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(TerBush and Novick, 1995), and we assayed for the presence
of the other exocyst subunits by quantitative Western blot
analysis. As can be seen in Figure 2, all six of the gain-of-
function alleles of EXO70 examined resulted in nearly identical
amounts of exocyst subunits being coprecipitated with Sec8-
myc. An exception was the EXO70-E557K allele which had a
small (25%) reduction in the mutant Exo70 protein coprecipi-
tated with the complex. However, this seems to mirror a sim-
ilar small reduction in the overall steady-state amounts of this
protein in the EXO70-E557K cells rather than an effect on
assembly or disassembly of the complex. Because the activation
of the exocyst complex with these gain-of-function mutants
seems to mimic the effect of Rho3/Cdc42 activation, these data
suggest that assembly and/or disassembly of the complex is
unlikely to be the central means of regulation by Rho3 and
Cdc42 GTPases.
The GTP-bound Forms of Rho3 and Cdc42, Produced in
Yeast, Interact with Exo70
The dominant suppressor analysis described above suggests
that Exo70 is probably a critical downstream target of both
Rho3 and Cdc42 regulation of exocytosis. However, work us-
ing recombinant forms of these GTPases produced in E. coli is
inconsistent with this notion. First, recombinant Cdc42-GTP
fails to show any detectable interaction with Exo70 (Figure 3A;
He et al., 2007a). Recombinant Rho3 does interact with Exo70 in
a GTP-dependent and effector domain-dependent manner
(Figure 3, A and B) but with relatively low affinity (Hamburger
et al., 2006). Second, mutations or deletions in Exo70 that se-
verely diminish this interaction in vitro fail to recapitulate
growth or secretory defects associated with either the rho3-V51
or cdc42-6 cells (He et al., 2007b; Hutagalung et al., 2009). Be-
cause nearly all small GTPases are subjected to posttransla-
tional modifications that do not occur after expression in E. coli,
we sought to determine whether we could detect an interaction
after their overexpression in yeast. To determine the nucleotide
dependence of this interaction, we made use of mutant forms
of Rho3 and Cdc42 which are predicted to “lock” the GTPases
in the either the GTP-bound conformation (Rho3-L74 or Cdc42-
L61) or GDP-bound conformation (Rho3-N30 or Cdc42-N17).
The nucleotide-locked forms of each GTPase were overex-
pressed (20-fold) using an inducible GAL1/10 promoter, and
the induced cells were used to make detergent lysates (see
Materials and Methods). These lysates were then used in binding
experiments with purified full-length Exo70 fused to GST or
various control GST-fusion proteins. A GST-fusion containing
Figure 2. Dominant mutations in Exo70 do not affect the as-
sembly of the exocyst complex. (A) Analysis of coimmunopre-
cipitation of exocyst subunits in EXO70 dominant mutant
strains. A single copy of C-terminal myc-tagged Sec8 (SEC8-
MYC) was introduced by integrative transformation into strains
containing dominant mutants of EXO70 (on CEN plasmid) as
the only source of Exo70 in the cell. Cells were grown, lysed,
and subjected to native immunoprecipitations with myc antibody to analyze the integrity of the exocyst complex (see Materials and Methods
for details). We loaded 12% of total lysate and 10% of myc immunoprecipitate on SDS-PAGE gel for Western blot analysis with antibodies
against each exocyst components. (B) Quantitation of Western blots described in A were performed by Odyssey infrared imaging system.
Top, quantitation of each individual subunit in the Sec8 Myc immunoprecipitation organized by strain. Bottom, comparison of wild type and
each gain of function strain organized by individual subunit. Error bars represent SD of four independent experiments.
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the C-terminal CRIB domain of the Ste20 protein was included
as a positive control for Cdc42. As can be seen in Figure 3C,
both the GTP-locked forms of Rho3 and Cdc42, Rho3-L74 and
Cdc42-L61, are specifically pulled down by GST-Exo70 and
this binding is nearly completely lost in lysates overex-
pressing the GDP-mutant forms of Rho3 and Cdc42,
Rho3-N30, and Cdc42-N17. In contrast to Rho3 and
Cdc42, no binding to Exo70 was detected with lysates
overexpressing GTP-locked Rho1, indicating that the in-
teraction with Exo70 is specific to Rho3 and Cdc42.
Because specific mutations in the effector domain of
Rho3 and Cdc42 have been described (rho3-V51 and
cdc42-6) that strongly interfere with the function of these
GTPases in promoting exocytosis (Adamo et al., 1999,
2001), we examined the effects of these mutations on
binding to Exo70. The effector mutations were incorpo-
rated in the context of a GTP-locked form of the GTPases
and overexpressed as described above. As can be seen in
Figure 3D, the presence of the V51 mutation causes a
severe defect in binding to Exo70. The cdc42-6 mutant
contains a cluster of three mutations (L29, V31, and H32)
in the effector domain that are critical to the temperature-
sensitive defect in exocytosis (Adamo et al., 2001). The
inclusion of these mutations in the context of a GTP-
locked form of Cdc42, causes a significant loss of binding
to GST-Exo70 (Figure 3D). Therefore, the Exo70 binding
with Rho3 and Cdc42 from yeast lysates presented here
shows clear specificity, nucleotide-dependence, and effec-
tor domain sensitivity expected for a bona fide assay for
GTPase:effector interaction.
Prenylation of Rho3 and Cdc42 Is an Important
Determinant for Binding to Exo70
One possible explanation for the results described above
is that a eukaryotic-specific posttranslational modification
such as prenylation of the C-terminal CAAX might be re-
quired for binding with Cdc42 and Exo70. We therefore
produced lysates of GTP-locked forms of Cdc42 and Rho3
with a mutation at the C-terminal Cysteine (in the CAAX
motifs) and monitored the effect on binding to recombinant
effector proteins. The results are shown in Figure 4. As ex-
pected the CAAX (C188A) mutation had no effect on binding of
Cdc42-L61 to GST-Ste20. In contrast, a dramatic loss of binding
to Exo70 was observed for Cdc42-L61,A188, suggesting that
C-terminal prenylation of Cdc42 is a prerequisite for binding.
Interestingly, we found that mutation of the CAAX motif of
activated Rho3 (L74,A228) also resulted in a dramatic loss of
binding to GST-Exo70, suggesting that the binding detected
Figure 3. Exo70 binding to Rho GTPases
expressed in E. coli or yeast. (A) Yeast Rho
GTPases (Rho1-4, and Cdc42) were expressed,
purified from bacteria as GST-fusion proteins,
and immobilized on glutathione-Sepharose
beads. The beads were preloaded with GTP and
bound to radiolabeled in vitro-translated full-
length Exo70 and the CRIB domain of Ste20.
Input represents 1% binding. (B) The V51 mu-
tation in the effector domain of Rho3 (Rho3V51)
abolishes the interaction between Rho3 and
Exo70 in vitro. Recombinant GST-Rho3 and
GST-Rho3V 51 were purified from bacteria
and the immobilized GST-fusion protein was
preloaded with GTPS or GDP. Input repre-
sents 1% binding. (C) Exo70 interacts with GTP-
locked Rho3 and Cdc42 obtained from a yeast
lysate. GST-fusion proteins were purified from
bacteria and immobilized on glutathione-
Sepharose beads. GTP or GDP locked forms of
small GTPases were expressed behind a galac-
tose inducible promoter in yeast. Lysates ob-
tained from these strains were used in the bind-
ing experiments (see Materials and Methods). The
input represents 2.5% binding. Bound material
was analyzed by Western blot using monoclo-
nal anti-Rho3, anti-Rho1, and anti-Cdc42 anti-
bodies. Because of the extremely strong binding
to Ste20 binding reactions with Cdc42-L61 (but
not Rho3, Rho1) were diluted 20-fold before
loading to improve quantitation and avoid ob-
scuring the adjacent lanes. (D) The interaction
between Exo70 and Rho3/Cdc42 obtained from
yeast is sensitive to mutations in the effector
domain of the two GTPases. The rho3V51, L74
and cdc42-6 effector domain mutations (cdc42-
L29, V31, H32, and L61) were expressed behind
a galactose inducible promoter in yeast. Lysates
generated from the overexpressing yeast strains
were subjected to binding experiments as de-
scribed above. (E) Bar graphs represent quanti-
tation of the blots using the Odyssey infrared
imaging system. Data were analyzed by two-
tail Student’s t test with error bars representing
SD from four independent experiments.
Exo70 Is an Effector for Cdc42/Rho3 Function In Exocytosis
Vol. 21, February 1, 2010 435
with recombinant Rho3 reflects only a residual level of inter-
action seen with the modified form of the protein.
To further examine the apparent requirement for CAAX
prenylation in the interaction between these Rho GTPases
and Exo70, we made use of rabbit reticulocyte lysates that
have been shown to be active in prenylating CAAX motifs in
vitro (Hancock, 1995). We examined whether we could de-
tect prenylation of either yeast GTPase after in vitro trans-
lation. When Rho3-L74 (GTP) or Rho3-N30 (GDP) were
translated in reticulocyte lysates and further incubated for
6 h, a faster migrating form of the protein appeared over
time. When activated Rho3 containing a mutation of the
critical cysteine (C228) in the CAAX motif was used, the
faster migrating form failed to appear (Figure 4B). The ad-
dition of mevalonic acid—a metabolic precursor of both
farnesyl and geranylgeranyl moieties used to modify CAAX
motifs—has been shown to stimulate both types of preny-
lation in reticulocyte lysates. As can be seen from Figure 4B,
the addition of mevalonic acid to the reaction after transla-
tion results in a dramatic increase in the conversion of
Rho3-L74 and Rho3-N30 proteins to the faster migrating
form but has no effect on the Rho3-L74,A228 mutant lacking
the prenylation acceptor cysteine.
We examined the ability of in vitro prenylated Rho3 from
reticulocyte lysates to bind to GST-Exo70 under conditions
similar to that used for the yeast lysate binding studies
described above. The results show that in vitro prenylated
Rho3-L74 (GTP-locked) binds well to the GST-Exo70,
whereas prenylated Rho3-N30 (GDP form) fails to bind (Fig-
ure 4C). Importantly, only very weak binding is seen when
unprenylated but activated Rho3-L74,A228 is present. Un-
like Rho3, we were unable to detect a cysteine-dependent
mobility shift in a parallel set of translations with Cdc42
translated in the reticulocyte system. However, when we
examined the binding of translations of activated Cdc42
(Cdc42L61) in the presence or absence of mevalonate and the
presence or absence of the C-terminal cysteine we find that
binding to Exo70 is dependent on GTP, the addition of
mevalonate, and the CAAX box. This provides strong evi-
dence that, like Rho3, prenylation of Cdc42 CAAX motif is
required for interaction with Exo70 in this system. Together
with the binding assays using GTPases from yeast lysates,
these data clearly demonstrate that prenylation of Rho3 and
Cdc42 is an important determinate in promoting the binding
between these Rho GTPase and Exo70.
Binding of Prenylated Rho3 and Cdc42 to Exo70 Is Not
Dependent on the C Domain
Previous studies to map the site of Rho3 interaction within
Exo70 depended largely on the use of recombinant (i.e., unpre-
nylated) forms of Rho3. These studies identified an important
role for C domain of Exo70 in mediating the interaction with
recombinant Rho3. Either mutations in, or deletion of, C do-
main of Exo70 result in dramatic loss of binding to Rho3 (Dong
et al., 2005; He et al., 2007b; Hutagalung et al., 2009). To deter-
mine whether prenylated Rho3 and Cdc42 were similarly de-
pendent on the Exo70 C domain for their interaction, we made
use of two mutant forms of Exo70, Exo70-1521 and Exo70-C.
Exo70-1521 has a combination of six alanine substitutions in
surface exposed residues within the C domain that block bind-
ing to recombinant Rho3 (He et al., 2007b), and Exo70-C
mutant contains a replacement of the entire C domain with an
Figure 4. Prenylation of Rho3 and Cdc42 pro-
motes the GTP-dependent interaction with
Exo70. (A) The interaction between Exo70 and
the two Rho GTPases, Rho3 and Cdc42, from
yeast lysate is dependent on C-terminal preny-
lation. Activated forms of Rho3 and Cdc42
(Rho3L74, Cdc42L61) containing a cysteine-to-
alanine mutation in the CAAX box (Rho3-L74,
A228, and Cdc42-L61, A188) were overex-
pressed in yeast. Lysates were prepared in par-
allel for these mutants and for the activated
GTPases containing the intact CAAX motif
(Rho3-L74 and Cdc42-L61) and used in binding
experiments (see Materials and Methods). Ste20
binding assays with Cdc42 (but not Rho3) were
diluted 20-fold before loading. As expected,
Ste20 binding was unaffected by the prenyla-
tion site mutation. Bar graphs represent quan-
titation of binding experiment with error bars
representing SD of three independent experi-
ments. Coomassie Blue staining of the GST-
fusion proteins used in the experiment is
shown below the quantitation. (B) In vitro pre-
nylation of Rho3 results in a change in mobility
and is stimulated by addition of mevalonic acid
to reticulocyte lysate. Rho3 was in vitro trans-
lated in rabbit reticulocyte lysates (see Materials
and Methods) and then subjected to extended
incubation (for the time shown) in the presence
or absence of mevalonic acid (MVA). The
appearance of a faster migrating species ap-
pears during the extended incubation and is
strongly stimulated by the addition of meval-
onic acid and is abolished by mutation of the CAAX box cysteine 228 to alanine. (C) The interaction between Exo70 and Rho3 and Cdc42 produced
in reticulocyte lysates is dependent on C-terminal prenylation. Immobilized GST-fusion proteins were incubated with prenylated Rho3 or Cdc42
obtained from the in vitro translation described in Materials and Methods. Input lanes for Rho3 binding experiments represent signal equivalent to
2.5% binding. Input lane for Cdc42 binding experiments represent signal equivalent to 10% binding. The Cdc42-N17 binding experiment was
exposed to film twice as long as the other experiments due to lower efficiency of translation for this mutant.
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eight residue flexible linker (Hutagalung et al., 2009). We com-
pared the binding of these two forms of Exo70 fused to GST to
equivalent amounts of wild-type full-length Exo70 by using the
Rho GTPases produced in yeast lysates. Remarkably, we found
that both GST-Exo70-1521 and GST-Exo70-C mutant proteins
showed binding activity to yeast Rho3-L74 and Cdc42-L61 that
was indistinguishable from that of wild-type Exo70 (Figure
5B). As before, this binding was highly dependent on the
activation status of the Rho3 and Cdc42. We repeated these
binding assays using the in vitro translated/in vitro preny-
Figure 5. Binding of prenylated Rho3 and Cdc42 to Exo70 does not depend on C domain. (A) Schematics of the Exo70-1521 mutation
and a domain C deletion. (B) Mutations in or a deletion of Exo70 domain C does not significantly affect the interaction between Exo70
and Rho3 or Cdc42 produced in yeast. Yeast lysates from cells overexpressing GTP or GDP locked Rho3 and Cdc42 were incubated with
immobilized GST-fusion proteins at different concentrations. Binding experiments were performed as described in Materials and
Methods. Graphs represent quantitation of the binding with error bars representing SD of three independent experiments. (C) Mutations
in or a deletion of Exo70 domain C does not significantly affect the interaction between Exo70 and Rho3 or Cdc42 prenylated in vitro
after translation in reticulocyte lysates. Immobilized GST proteins were incubated with prenylated Rho3 and Cdc42 obtained from the
in vitro translation as described in Materials and Methods. Input lanes for Rho3 binding experiments represent signal equivalent to 2.5%
binding. Input lane for Cdc42 binding experiments represent signal equivalent to 10% binding. The Cdc42-N17 binding experiment was
exposed to film twice as long as the other experiments due to lower efficiency of translation for this mutant. Shown below is Coomassie
Blue staining of the GST fusion proteins used for binding and bar graphs representing quantitation of the binding with error bars
representing SD of three independent experiments.
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lated Rho3 protein. Using the in vitro modified Rho3, we see
a small loss of binding activity to the GST-Exo70-1521 and
GST-Exo70-C mutant proteins, but both mutants demon-
strate very clear binding which is highly dependent on both
the activation (i.e., GTP) and prenylation status of Rho3.
Therefore, both of these assays reveal that Exo70 is able to
interact with Rho GTPases in a manner that does not depend
on the C domain and that the prenylation state of these GTPases
seems to be critical in revealing this mode of interaction. It is
worth noting that mammalian TC10 GTPase (produced in NIH
3T3 cells and hence probably prenylated) also has been shown
to interact with mammalian Exo70 in a manner that does not
depend of the C domain (Chiang et al., 2001).
Isolation of Novel Conditional-Lethal Alleles of EXO70
A previous screen for mutants in EXO70 resulted in the
identification of two alleles, exo70-38 and exo70-35, with
unusual phenotypes nearly identical to those described for
cdc42-6 (He et al., 2007a). Like cdc42-6 mutants, exo70-38 and
exo70-35, exhibit defects in secretion of Bgl2 but not inver-
tase and show accumulation of post-Golgi vesicles in small-
but not large-budded cells. Invertase and Bgl2 are thought to
be delivered to the cell surface through two distinct popu-
lations of post-Golgi vesicles, and both populations are
blocked by all of the original 10 late sec mutants (Harsay and
Bretscher, 1995). The remarkable similarity of the unusual
phenotypes of the exo70-38 and exo70-35 mutants with the
cdc42-6 mutant gives strong in vivo support for the notion
that Exo70 is a direct effector of Cdc42 function in exocytosis,
as suggested by the dominant suppressor and biochemical
interaction studies described above. However, the pheno-
types associated with the exo70-38 and exo70-35 mutants are
not consistent with the model that Exo70 is a downstream
effector of the Rho3 GTPase. The rho3-V51 mutant has sig-
nificantly more expansive secretory defects than seen in
these two mutants. Specifically, the rho3-V51 mutant shows
pronounced defects in both invertase and Bgl2 secretion and
accumulates post-Golgi vesicles in both small and large
budded cells. Because these phenotypes are at odds with the
genetic and biochemical studies described above linking
Exo70 as a downstream effector of both GTPases, we postu-
lated that the exo70-38 and exo70-35 mutants might represent
hypomorphic alleles of EXO70, defective in transmitting
Cdc42 function but still permissive for promoting Rho3
function. To test this idea, we set out to identify and char-
acterize novel conditional-lethal alleles in EXO70 and de-
scribe the loss-of-function phentoypes associated with them.
To identify additional alleles of EXO70 with recessive
conditional growth defects, we screened a library of random
PCR-generated exo70 mutants by using a plasmid shuffle
strategy (see Materials and Methods). After growth on 5-FOA
media at 25°C (to evict the EXO70 plasmid and reveal pos-
sible recessive phenotypes), 57 independent colonies were
identified that exhibited low-temperature–sensitive growth
at 14°C (cs), and 40 colonies were identified that exhibited
high-temperature–sensitive (ts) growth. After recovery of
the mutant plasmids from these strains and retransforma-
tion into the exo70/CEN-URA3-EXO70 plasmid shuffle
strain, we identified one plasmid containing a cold-sensitive
allele (exo70-188), and one plasmid containing a tempera-
ture-sensitive allele (exo70-113). These alleles (as well as
wild-type EXO70 control) were then integrated at the EXO70
locus by replacing a disruption in a heterozygous diploid.
After sporulation and tetrad dissection, the pattern of spores
showing conditional growth was seen to be tightly linked to
the newly introduced allele. Thus the phenotypes of the inte-
grated alleles were similar to that of the original plasmid-borne
mutants. These integrated mutant strains were then used for all
the subsequent analyses of the growth and secretion pheno-
types associated with these new alleles of exo70.
We examined the exo70-188cs allele for its ability to se-
crete invertase and Bgl2 at permissive temperature (25°C)
and after a 9-h shift to the nonpermissive conditions (14°C).
A wild-type EXO70 and cold-sensitive rho3-V51 strain were
assayed in parallel as negative and positive controls for
cold-sensitive secretory defects. As can be seen in Figure 6,
B and C, the exo70-188 mutant shows pronounced invertase
and Bgl2 secretion defects at 14°C (relative to EXO70), and
both the magnitude and temperature dependence of these
secretory effects are remarkably similar to that seen in rho3-
V51 cells (Roumanie et al., 2005). When exo70-188 cells were
shifted to 14°C and then examined by thin-section electron
microscopy, a highly penetrant (80% of cells) and dramatic
(75 vesicles/cell on average) accumulation of 80- to
100-nm post-Golgi vesicles was apparent (Figure 6, D and
E). As we had seen previously with rho3-V51, and consistent
with the secretion data, a lower—and less penetrant—level
of vesicle accumulation was observed in exo70-188 mutants
grown at the permissive temperatures (Figure 6, D and E).
To determine whether there was an effect of the stage of the
cell cycle on vesicle accumulation in this mutant, we com-
pared the vesicle accumulation in cells with small (	1-m-
diameter) buds compared with larger (1-m-diameter)
buds, as we have previously with cdc42-6 and exo70-38. The
results, shown in Figure 6D clearly demonstrate that both
large- and small budded exo70-188 cells have a similar high
degree of penetrance and vesicle accumulation at both per-
missive and nonpermissive temperatures.
The temperature-sensitive exo70-113 mutant was character-
ized in a similar manner except that cells were shifted to 37°C
for 2 h to examine the effect of temperature-shift on exocytic
function. An isogenic wild-type EXO70 and sec6-4 mutant were
examined in parallel as controls. As can be seen in Figure 7, B
and C, the exo70-113ts mutant shows pronounced invertase
and Bgl2 secretion defects after a shift to 37°C and when
examined by thin section electron microscopy, a highly pene-
trant (80% of cells) and strong (80 vesicles/cell, on average)
accumulation of 80- to 100-nm post-Golgi vesicles was appar-
ent in both large- and small-budded cells (Figure 7, D and E).
Together, our analysis of these two new alleles demonstrates
that Exo70 function is required for all the secretory functions
seen with other late-acting sec genes including secretion of both
the Bgl2 and the invertase class of vesicles, and exocytosis in
early bud emergence as well as in later stages of bud growth.
These observations are important to the present study because
they demonstrate that the spectrum of phenoytpes associated
with loss-of Exo70 function is entirely consistent with Exo70
being a downstream effector of both Cdc42 and Rho3 function
in exocytosis.
DISCUSSION
We have previously characterized a role for Cdc42 and Rho3 as
positive regulators of exocytosis and found that this role was
independent of polarization of both the actin cytoskeleton and
of the exocyst complex (Roumanie et al., 2005). We suggested a
model where these GTPases would work by locally increasing
the activity (or throughput) of the exocytic apparatus at sites
occupied by GTP-bound Rho/Cdc42 proteins (Roumanie et al.,
2005; Wu et al., 2008). However, the precise effector pathway by
which such a mechanism would take place was either un-
known—as for Cdc42—or highly controversial—as for Rho3.
In this report, we provide three independent lines of evidence
that strongly supports this model of regulation and demon-
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strates that the Exo70 component of the exocyst complex rep-
resents a critical and direct effector for both Rho3 and Cdc42
function in spatial regulation of exocytosis.
Several studies have been carried out to investigate the
interaction of Exo70 and Rho family GTPases in yeast and
mammalian cells. However, despite the fact that both yeast
and mammalian Exo70 have been reported to bind Rho
family GTPases and the overall structural similarity between
yeast and mammalian Exo70 proteins is very high through-
out their length, the sites of interaction reported for the
Figure 6. Characterization of a novel cold-sensitive mutant exo70-188. (A) Growth prop-
erties of the cold sensitive mutant, exo70-188 at permissive and nonpermissive tempera-
tures. Wild-type EXO70 and exo70-188 mutant alleles were integrated at the EXO70 locus.
Ten-fold serial dilutions of yeast cells were grown on YPD plates at the indicated temper-
atures. (B) The exo70-188 mutant is defective in secretion of the periplasmic enzyme
invertase. Invertase assays were conducted on cells shifted to low glucose media at the
permissive temperature (25°C) for 2 h or the restrictive temperature (14°C) for 9 h. The
graph shows the percentage of internal invertase at 25 and 14°C in each strain analyzed.
The error bars represent SD of five independent experiments. (C)The exo70-188 is defective
in Bgl2 secretion. Bgl2 assays were performed on cells kept at permissive temperature or
shifted to restrictive temperature for 9 h. The percentage of distribution of Bgl2 was
determined by immunoblot analysis using affinity-purified Bgl2 antibody. The graph de-
picts the percentage of Bgl2 protein that remains internal in EXO70, exo70-188, and rho3-V51 strains. Quantitations were performed by
Odyssey infrared imaging system. Error bars represent SD of four independent experiments. (D) The exo70-188 mutant accumulates
post-Golgi vesicles in both large-budded cells and small-budded cells. The exo70-188 mutant cells kept at the permissive temperature or
shifted to restrictive temperature for 9 h were fixed and processed for electron microscopy. Examples of both small- (	1-m) and
large-budded (1-m) cells are shown. Cells were scored for number of vesicles accumulated throughout the cell and bar graphs show the
percentage of small-budded or large-budded cells containing different number of vesicles. Bar, 2 m. (E) Overall post-Golgi vesicle accumulation
was determined for electron microscopy sections by scoring cells 3 m in diameter (irrespective of bud or bud size) for 80- to 100-nm vesicles.
For each condition, micrographs were divided into three groups representing 20–25 cells each to determine the SD in this assay.
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GTPases seemed to be quite distinct. Studies using tagged-
TC10 in transfected mammalian cells identified a region
within domains A and B in mouse Exo70 as the major site of
binding, whereas studies using recombinant Rho3 have
identified a binding site within C domain as the major
binding site for the yeast Exo70 protein (Dong et al., 2005; He
et al., 2007b; Hutagalung et al., 2009). To make matters more
difficult, mutations or deletions in Exo70 that block recom-
binant Rho3 binding had little or no effect on growth or
secretion of yeast cells containing these mutant exo70 alleles
as the sole source of Exo70 in the cell (He et al., 2007b;
Hutagalung et al., 2009). Finally, phenotypic analysis of two
Figure 7. Characterization of a novel temperature-sensitive mutant exo70-113. (A) Growth defect
of a novel temperature sensitive mutant exo70-113. Wild-type EXO70 and exo70-113 alleles were
integrated at the EXO70 locus. Ten-fold serial dilutions of yeast cells were grown on YPD plates
at the indicated temperatures. (B) The exo70-113 mutant is defective in secretion of the periplasmic
enzyme invertase. Invertase assays were performed on cells after a 2-h shift to low glucose media
at permissive (25°C) or a 1.5-h shift to restrictive temperature (37°C). The graph shows the
percentage of internal invertase in the strains analyzed. The error bars represent SD of four
independent experiments. (C) exo70-113 is defective in Bgl2 secretion. Bgl2 assays were performed
on cells kept at permissive temperature or shifted to the restrictive temperature of 37°C for 2 h.
The percentage of distribution of Bgl2 was determined by immunoblot analysis using affinity-
purified Bgl2 antibody. The graph depicts the percentage of Bgl2 protein that remains internal in
EXO70, exo70-113, and sec6-4 strains. Quantitations were performed by Odyssey infrared imaging
system. Error bars represent SD of four independent experiments. (D) exo70-113 mutant accumulates post-Golgi vesicles in both large-budded
cells and small-budded cells. exo70-113 mutant cells kept at the permissive temperature or shifted to restrictive temperature for 2 h were fixed
and processed for electron microscopy. Examples of both small- (	1-m) and large-budded (1 m) cells are shown. Cells were scored for
number of vesicles accumulated throughout the cell, and bar graphs show the percentage of small-budded or large-budded cells containing
different number of vesicles. Bar, 2 m. (E) Overall post-Golgi vesicle accumulation was determined for electron microscopy sections by
scoring cells 3 m in diameter (irrespective of bud or bud size) for 80- to 100-nm vesicles.
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conditional alleles of exo70 showed exocytic phenotypes that
were remarkably similar to that of cdc42-6 but very distinct
from that of rho3-V51 (He et al., 2007a). However, despite the
similarity in phenotypes with the Cdc42 mutant, biochemi-
cal analyses failed to show any detectable interaction be-
tween Exo70 and recombinant GTP-bound forms of Cdc42
(He et al., 2007a, this study). Collectively these results
seemed to be entirely incompatible with the notion that
Exo70 was a direct effector of Cdc42 or Rho3 in yeast. More-
over, the ability of Exo70 family members to interact with
Rho GTPases is highly conserved in yeast and mammals,
suggesting that structurally divergent mechanisms had
evolved into interactions with completely distinct regions of
the yeast and mammalian Exo70 proteins.
We have spent considerable effort to find conditions for
examining the interaction of Exo70 and either Rho3 or Cdc42
by coimmunoprecipation from detergent lysates. Despite
numerous attempts we have been unable to detect this in-
teraction by this method. This may reflect the relatively low
affinity of these interactions because, in vivo, these interac-
tions occur on the plasma membrane where the local con-
centrations of both GTPases and the Exo70 effector are much
higher than after lysis in detergent-containing buffer.
A key finding to unraveling these apparently contradic-
tory observations was the use of post-translationally modi-
fied forms of Rho3 and Cdc42 in our Exo70 binding studies,
a strategy similar to that used to map the TC10 interaction
with mammalian Exo70. In particular, we found that muta-
tion of the cysteine present in the C-terminal CAAX motif of
either Cdc42 or Rho3 resulted in a dramatic loss of interac-
tion with Exo70. Because this modification does not occur in
bacterially-produced forms of these GTPases, the absence of
this modification is probably responsible for the dramatic
differences seen in the binding assays described here from
those described previously. Furthermore, because the map-
ping of the binding of the Cdc42 homologue TC10 to mouse
Exo70 made use of a mammalian expression system (hence,
prenylated TC10), this may explain the apparent distinction
in the site of binding between the yeast and mammalian
forms of Exo70. Further mapping of the Rho GTP binding
site in both yeast and mammalian Exo70 will be necessary to
determine how structurally similar these binding events are.
Because Rho3 and Cdc42 are predicted to be prenylated with
different prenyl moieties—Rho3 with farnesyl and Cdc42
with geranlygeranyl—we think it unlikely that the prenyl
groups themselves are part of the effector interaction.
Rather, we suggest that the presence of the prenyl group is
likely to affect presentation of the GTP-bound Rho protein to
Exo70 in the context of the detergent micelles present in the
binding assays. This may reflect the nature of the interaction
that probably occurs in proximity to the membrane in vivo,
because both Exo70 and the GTPase have C-terminal mem-
brane-targeting motifs. A role for prenylation in effector
binding is unusual but not unprecedented. Ohya and col-
leagues (Inoue et al., 1999) demonstrated that the physical
interaction of Rho1 with its effector Fks1 was highly depen-
dent on the C-terminal geranylgeranylation. It remains to be
seen whether other Rho effector relationships depend on
prenylation because this is it not a feature that is commonly
examined.
What does “activation” of the exocyst by Rho GTPases do
to regulate exocytosis? In its simplest form, this activation
would involve an increase in the rate of vesicle docking and
fusion at a specific place on the plasma membrane demar-
cated by the GTP-bound form of Cdc42 and/or Rho3. Be-
cause the loss of function mutants in cdc42 and rho3 fail to
show a detectable effect on polarization of Sec4 or exocyst
subunits to sites of polarized growth, and the mutants are
strongly suppressed by increased levels of the target mem-
brane-soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (SNARE) Sec9, we favor the model that
these GTPases act through the exocyst to increase localized
SNARE assembly leading to more rapid vesicle fusion. The
details of how this activation mechanism works remain to be
elucidated. However, because dominant alleles of Exo70
described here act as though they are “constitutively active”
forms of Exo70they will be valuable tools in helping to
understand the nature of this activation. For example, all of
the gain-of-function mutants seem to have similarly fully
assembled exocyst complex, suggesting that assembly
and/or disassembly of the complex is unlikely to represent
the major mode of regulation by these GTPases.
In addition to Exo70, Sec3—another component of the
exocyst complex—has been proposed to be an effector in
regulating polarized growth downstream of the Rho1 and
Cdc42 GTPases (Guo et al., 2001; Zhang et al., 2008; Hutaga-
lung et al., 2009). However, it is unlikely that Sec3 is the
principal effector for Cdc42 function in exocytosis. First,
deletion of the N-terminal Rho-binding domain of Sec3 is
nonessential and has no detectable impact on polarized
growth or secretion at any temperature, whereas the cdc42-6
mutant results in a severe temperature-sensitive growth and
secretion defect. Second, we have shown previously that
deletion of the Sec3 N-terminal domain results in a synthetic
lethal phenotype when combined with the cdc42-6 mutant,
which strongly suggests that this domain of Sec3 has an
important role that acts in parallel (perhaps through Rho1
signaling) with Cdc42 signaling through Exo70 (Roumanie
et al., 2005). In agreement with the idea that the Cdc42–Exo70
pathway functions in parallel with a Sec3–Rho pathway, sev-
eral groups have shown synthetic lethality between sec3-DNT
and several EXO70 loss-of-function mutants (Zhang et al., 2008;
Hutagalung et al., 2009). It also important to note that although
the Exo70 effector activity seems to be regulated by both Rho3
and Cdc42 but not Rho1, the N terminus of Sec3 has been
reported to interact with both Rho1 and Cdc42 but not Rho3.
Therefore, this process seems to be regulated by a complex
network of partially overlapping Rho GTPase/effector rela-
tionships which may provide increased robustness to the over-
all spatial regulation of polarized exocytosis.
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